TCTR20210907003
Not yet recruiting
Phase 1
A Pilot Study: Safety and Immunological Response following Intradermal COVID-19 vaccination in The Booster (3rd dose)
Faculty of Medicine Siriraj Hospital, Mahidol University0 sites60 target enrollmentSeptember 7, 2021
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- healthy volunteer
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Enrollment
- 60
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Males or females at least 18 years of age (inclusive), 2\. Have completed primary series of COVID\-19 vaccines (2 doses of Sinovac, AstraZeneca, or mRNA) between 6\-10 weeks?, 3\. Can understand Thai language through speaking, reading and writing?, 4\. Able to communicate through electronic tools such as Google form or line., 5\. Capable of attending all study visits according to the study schedule., 6\. Capable of informed consent and provision of written informed consent before any study procedures
Exclusion Criteria
- •1\. Have history of severe drug or vaccine allergy (anaphylaxis)?, 2\. Have ever been detected COVID\-19 infection?, 3\.Have any history of contacting COVID\-19 patient (high risk contact)?, 4\. Positive result of antigen test kit?, 5\. Have received blood transfusion, plasma, blood product, blood component, immunoglobulins, antiviral or antibodies within the last 90 days?, 6\.Have history of cigarettes smoking, alcohol drinking and history of drug abuse? , 7\. Being pregnant?, 8\. Have unstable disease or could not control the symptom?, 9\. Have history of immunodeficiency or been using immunosuppressant or steroid drugs?, 10\. Have any unusual symptoms or medical history that considered unable to participate in the study?
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 1
A Pilot Study: Safety and Immunological Response following Intradermal COVID-19 vaccination with Accelerate RegimeHealthy volunteerCOVID-19vaccinesafetyimmunological responseintradermalAccelerate RegimenTCTR20210904004Health Systems Research Institute (HSRI)60
Not yet recruiting
Phase 1
A Pilot Study: Safety and Immunological Response following Intradermal COVID-19 vaccinatiohealthy volunteerSafety and Immunological ResponseIntradermalCOVID-19 vaccinationTCTR20210903006Faculty of Medicine Siriraj Hospital, Mahidol University80
Recruiting
Phase 2
Preliminary study: Safety and Immunological Response following COVID-19 Vaccination in COVID-19 survivorsCOVID-19 survivorsCOVID-19 VaccinationTCTR20210720005Faculty of Medicine Siriraj Hospital180
Active, not recruiting
Not Applicable
Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and ChildreJapanese EncephalitisTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2015-005193-38-Outside-EU/EEASanofi Pasteur SA300
Recruiting
Phase 1
A pilot study to evaluate the safety and efficacy of a personalised cancer vaccine in patients with completely resected early stage lung cancerACTRN12619000769189niversity of Western Australia6